General Information
DRAVP ID DRAVPe01722
Peptide Name P1(SARS-CoV (1153-1189))
Sequence GINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE
Sequence Length 37
UniProt ID P59594
Taxon ID None
Source Synthetic construct
Validation Experimentally Validated
Origin Information
Gene Name/ID Not Available
GenBank Not Available
Amino Acid position Not Available
Domain Accession ID Not Available
Nucleotide sequence ID Not Available
Molecular Type Not Available
Chromosomal Position Not Available
Activity Information
Target Organism SARS-CoV
Assay cell fusion inhibition assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target membrane
Mechanism Binding to the HR1 region and blocking the formation of a 6-helix bundle during the fusion step of virus entry, thus inhibiting virus entry.
Structure Information
PDB ID None
Predicted Structure Download No predicted structure available
Linear/Cyclic Linear
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C181H302N50O62
Absent amino acids CFHMPTW
Common amino acids ELN
Mass 4170.69
Pl 4.49
Basic residues 4
Acidic residues 7
Hydrophobic residues 14
Net charge -3
Boman Index -7238
Hydrophobicity -42.43
Aliphatic Index 123.78
Half Life
Extinction Coefficient cystines 1490
Absorbance 280nm 41.39
Polar residues 10
Literature Information
Literature 1
Title Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.
Pubmed ID 18983873
Reference Antiviral Res. 2009 Jan;81(1):82-7.
Author Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.
Literature 2
Title Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
Pubmed ID 15043961
Reference Lancet. 2004 Mar 20;363(9413):938-47.
Author Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S.